Clinical Research Directory
Browse clinical research sites, groups, and studies.
Using e-Nose Technology to Identify Early Lung Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Summary
The purpose of this study is to test the ability of a new technology called breathprinting, or electronic nose (e-nose), to detect early-stage lung cancer. Additionally, researchers also want to see if the e-nose technology is more effective at diagnosing lung cancer if the tumor size is larger.
Official title: Breathprinting (e-Nose) Technology for the Identification of Early-Stage Lung Cancer
Key Details
Gender
All
Age Range
21 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
119
Start Date
2021-01-25
Completion Date
2026-01-25
Last Updated
2025-05-16
Healthy Volunteers
No
Conditions
Interventions
Breathprinting test
Consented, enrolled participants will undergo a breathprinting test (e-nose) during the presurgical visit and at the same facility as their presurgical or prebiopsy visit, before any attempt is made to obtain cytohistological diagnosis of the pulmonary nodule.
Locations (7)
Memorial Sloan Kettering Basking Ridge (Consent only)
Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Consent only)
Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Consent only )
Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only)
Commack, New York, United States
Memorial Sloan Kettering Westchester (Consent only)
Harrison, New York, United States
Memorial Sloan Kettering Cancer Center (All Study Activities)
New York, New York, United States
Memorial Sloan Kettering Nassau (Consent Only)
Uniondale, New York, United States